InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV)’s stock price passed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $1.01 and traded as high as $1.04. InVivo Therapeutics shares last traded at $1.01, with a volume of 778,293 shares.
The stock’s 50 day moving average is $1.16 and its two-hundred day moving average is $1.01.
A hedge fund recently bought a new stake in InVivo Therapeutics stock. Renaissance Technologies LLC bought a new position in InVivo Therapeutics Holdings Corp. (NASDAQ:NVIV) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 111,474 shares of the biotechnology company’s stock, valued at approximately $90,000. Renaissance Technologies LLC owned approximately 0.53% of InVivo Therapeutics as of its most recent filing with the Securities and Exchange Commission (SEC). 0.48% of the stock is currently owned by institutional investors.
About InVivo Therapeutics (NASDAQ:NVIV)
InVivo Therapeutics Holdings Corp., a research and clinical-stage biomaterials and biotechnology company, engages in developing and commercializing biopolymer scaffolding devices for the treatment of spinal cord injuries (SCI). The company is developing a Neuro-Spinal Scaffold implant, which is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord to treat acute SCI.
See Also: What is the Consumer Price Index (CPI)?
Receive News & Ratings for InVivo Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for InVivo Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.